Prevalence and Characterization of MET Overexpression in Chinese NSCLC Patients: A Retrospective Real-World Analysis

被引：0
|
作者：
Yang, L. [1 ]
Li, J. [1 ]
Li, Y. [1 ,2 ]
Lin, R. [1 ]
Li, Y. [1 ,2 ]
Chen, J. [1 ]
Lai, X. [1 ]
机构：
[1] Wenzhou Med Univ, Affiliated Hosp 1, Wenzhou, Peoples R China
[2] Wenzhou Med Univ, Affiliated Hosp 2, Wenzhou, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 10期
关键词：
MET overexpression; adenocarcinomas;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP.04E.05
引用
收藏
页码：S480 / S480
页数：1
相关论文
共 50 条
  • [41] Retrospective Analysis of Real-World Clinico-Genomic Data for Clinical Impact of Genomic Profiling of ctDNA in NSCLC
    Madison, R.
    Schrock, A.
    Gregg, J.
    Carson, K.
    Castellanos, E.
    Singal, G.
    Miller, V.
    Ali, S.
    Alexander, B.
    Chung, J.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S364 - S365
  • [42] South Korean real-world treatment patterns in patients with EGFRm NSCLC
    Lee, J. C.
    Kim, Y-C.
    Lee, S. Y.
    Yoo, S. S.
    Davis, K.
    Nagar, S. P.
    Sawyer, W.
    Yu, N.
    Taylor, A.
    ANNALS OF ONCOLOGY, 2020, 31 : S1403 - S1403
  • [43] Ethnic disparities in biomarker testing of patients with metastatic NSCLC in the United States: A real-world analysis
    Jayram, Diya
    Bellur, Shreyas S.
    Ozair, Ahmad
    Ahmad, Shahzaib
    Ganiyani, Mohammad Arfat
    Khosla, Atulya Aman
    McCracken, Andrea
    Marada, Suresh
    Hurmiz, Charlie
    Bowman, Steven, II
    Ahluwalia, Manmeet Singh
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [44] CONTEMPORARY REAL-WORLD EVIDENCES ON ALK plus NSCLC PATIENTS IN ITALY
    Tucci, C.
    Trimarchi, C.
    Urbinati, D.
    Demma, F.
    Fico, M.
    Fioravanti, L.
    VALUE IN HEALTH, 2018, 21 : S50 - S51
  • [45] Is there an Exposure-Response Relationship for Nivolumab in Real-World NSCLC Patients?
    Bellesoeur, Audrey
    Ollier, Edouard
    Allard, Marie
    Hirsch, Laure
    Boudou-Rouquette, Pascaline
    Arrondeau, Jennifer
    Thomas-Schoemann, Audrey
    Tiako, Manuela
    Khoudour, Nihel
    Chapron, Jeanne
    Giraud, Frederique
    Wislez, Marie
    Damotte, Diane
    Lupo, Audrey
    Vidal, Michel
    Alexandre, Jerome
    Goldwasser, Francois
    Tod, Michel
    Blanchet, Benoit
    CANCERS, 2019, 11 (11)
  • [46] Real-world safety of pemetrexed, carboplatin, and pembrolizumab in US NSCLC patients
    Muehlenbein, Catherine
    Kim, Sangmi
    Ryabko, Ekaterina
    Oton, Ana
    Agg, Himani
    Smolyakova, Natalia
    Kim, Jong Seok
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (05)
  • [47] END OF LIFE RESOURCE USE OF REAL-WORLD NSCLC PATIENTS IN FINLAND
    Ekroos, H.
    Koistinen, V
    Holsae, O.
    Mannerstrom, B.
    Mattila, R.
    Knuuttila, A.
    VALUE IN HEALTH, 2024, 27 (12)
  • [48] PREVALENCE, REAL-WORLD HEALTHCARE RESOURCE UTILIZATION, AND COSTS OF PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA IN THE US: A RETROSPECTIVE CLAIMS DATABASE ANALYSIS
    Tantravahi, S.
    Latremouille-Viau, D.
    Desai, R.
    Lee, S.
    Paulose, J.
    Geevarghese, A.
    Guerin, A.
    Seshasayee, S.
    Tabatabaeepour, N.
    Chanpura, M.
    Yen, G.
    VALUE IN HEALTH, 2024, 27 (06) : S140 - S140
  • [49] MET overexpression correlated with prognosis of EGFR-mutant treatment-naïve advanced lung adenocarcinoma: a real-world retrospective study
    Wang, Na
    Zhang, Yuan
    Wu, Junhua
    Zhu, Yili
    Wu, Ying
    Huang, Bo
    Zhang, Ruiguang
    Fan, Jun
    Nie, Xiu
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2024, 26 (07): : 1696 - 1707
  • [50] A retrospective multicenter characterization of patients with metastatic renal cell carcinoma: the Sicilian "real-world" experience
    Incorvaia, L.
    Badalamenti, G.
    Rizzo, S.
    Cicero, G.
    Rinaldi, G.
    Bazan, V.
    Marchese, A.
    Ancona, C.
    Piazza, D.
    Spada, M.
    Butera, A.
    Valenza, R.
    Blasi, L.
    Verderame, F.
    Adamo, V.
    Di Cristina, L.
    Borsellino, N.
    Savarino, A.
    Zerilli, F.
    Russo, A.
    ANNALS OF ONCOLOGY, 2016, 27
12345